Frontlight ResearchEarly access
Trial site
Incheon
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Stroke2 trials
- Acute lymphoblastic leukaemia1 trial
- Alzheimer disease1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Lung cancer1 trial
- and 1 more
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals12 trials
Running trials
Active, not recruiting
Active, not recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
Recruiting
Recruiting
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026